TACE vs. LR: Better prognosis in HCC with bile duct tumor thrombus?April 26, 2022Hepatocellular Carcinoma
TACE is safe and effective in elderly patients with intermediate HCCApril 26, 2022Hepatocellular Carcinoma
Tenofovir vs. entecavir: Better therapeutic in HBV-related HCC after radiofrequency ablationApril 26, 2022Hepatocellular Carcinoma
Unresectable HCC: Suboptimal response to lenvatinib plus pembrolizumab beyond the first-line settingApril 26, 2022Hepatocellular Carcinoma
Preliminary results call for evaluating AtezoBev in unresectable HCC beyond the CP-A criteriaApril 26, 2022Hepatocellular Carcinoma
Adjuvant SBRT after marginal resection: A safe therapeutic option for MVI-positive HCC April 26, 2022Hepatocellular Carcinoma
Surveillance for HCC occurrence in NAFLD: Why concentrate our efforts?April 26, 2022Hepatocellular Carcinoma
On-treatment HCC risk is inversely related to baseline viral load in HBeAg-positive chronic hepatitis BApril 26, 2022Hepatocellular Carcinoma
Aspirin use may be protective against HCC in chronic hepatitis BApril 26, 2022Hepatocellular Carcinoma
Active HCV infection worsens the prognosis of very early-stage HCC after ablation therapyMarch 21, 2022Hepatocellular Carcinoma
Risk factors for recurrence after hepatic resection for early-stage HCCMarch 21, 2022Hepatocellular Carcinoma
